Gradientech is pleased to announce positive study results obtained from clinical blood culture samples using QuickMIC, Gradientech’s ultra-rapid antibiotic susceptibility testing (AST) system. The antibiotic susceptibility results were available in an average of 3 hours, which is considerably faster than any other phenotypic AST method in the market.
Gradientech AB (publ) interim report for Q1 2021 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q1 2021 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech’s annual report for 2020 has today been published on the company’s website.
Gradientechs årsredovisning för 2020 har idag publicerats på bolagets hemsida.
Already a winner of the RedDot Design Award2021, Gradientech has been awarded this year’s iF DESIGN AWARD for its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing. The iF DESIGN AWARD is granted to products with outstanding design.
Gradientech has been awarded the Red Dot Award: Product Design 2021 for its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing. The Red Dot Award is awarded to products that feature truly exceptional design.
Gradientech AB (publ) year-end report for 2020 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech AB:s (publ) bokslutskommuniké för 2020 finns nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech AB (publ) today announced that their QuickMIC system for rapid antibiotic susceptibility testing (AST) is currently being used for a beta test study by Uppsala University Hospital, Sweden.